Journal List > J Korean Acad Nurs > v.41(4) > 1002735

Choe and An: Effects of Nitric Oxide Synthase Inhibitor on Hindlimb Muscles in Rats with Neuropathic Pain Induced by Unilateral Peripheral Nerve Injury

Abstract

Purpose

The purpose of this study was to examine effects of nitric oxide synthase (NOS) inhibitor on muscle weight and myofibrillar protein content of affected and unaffected hindlimb muscles in rats with neuropathic pain induced by unilateral peripheral nerve injury.

Methods

Neuropathic pain was induced by ligation and cutting of the left L5 spinal nerve. Adult male Sprague-Dawley rats were randomly assigned to one of two groups: The NOSI group (n=19) had NOS inhibitor (L-NAME) injections daily for 14 days, and the Vehicle group (n=20) had vehicle injections daily for 14 days. Withdrawal threshold, body weight, food intake and activity were measured every day. At 15 days all rats were anesthetized and soleus, plantaris and gastrocnemius muscles were dissected from hindlimbs. Muscle weight and myofibrillar protein content of the dissected muscles were determined.

Results

The NOSI group showed significant increases as compared to the Vehicle group for body weight at 15 days, muscle weight and myofibrillar protein content of the unaffected soleus and gastrocnemius. The NOSI group demonstrated a higher pain threshold than the vehicle group.

Conclusion

NOSI for 14 days attenuates unaffected soleus and gastrocnemius muscle atrophy in neuropathic pain model.

Figures and Tables

Figure 1
Time course of changes in withdrawal threshold.
*p<.05.
NOSI=Nitric oxide synthase inhibitor.
jkan-41-520-g001
Table 1
Body Weight and Total Diet Intake of NOSI and Vehicle Rats
jkan-41-520-i001

NOSI=Nitric oxide synthase inhibitor.

Table 2
Mean Daily Activity Score of NOSI and Vehicle Rats
jkan-41-520-i002

NOSI=Nitric oxide synthase inhibitor.

Table 3
Muscle Weight of NOSI and Vehicle Rats
jkan-41-520-i003

NOSI=Nitric oxide synthase inhibitor.

Table 4
Myofibrillar Protein Content of the Hindlimb Muscles in NOSI and Vehicle Rats
jkan-41-520-i004

NOSI=Nitric oxide synthase inhibitor.

Notes

This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (R01-2007-000-10573-0).

References

1. American College of Sports Medicine. ACSM's advanced exercise physiology. 2006. Philadelphia: Lippincott Williams & Wilkins.
2. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods. 1994. 53:55–63. doi: 10.1016/0165-0270(94)90144-9.
3. Choe MA, An GJ. Effect of dehydroepiandrosterone on affected and unaffected hindlimb muscles in rats with neuropathic pain induced by unilateral peripheral nerve injury. Journal of Korean Academy of Nursing. 2009. 39:632–640. doi: 10.4040/jkan.2009.39.5.632.
4. Choe MA, An GJ. Effects of exercise on affected and unaffected hindlimb muscles in rats with neuropathic pain induced by unilateral peripheral nerve injury. Journal of Korean Academy of Nursing. 2010. 40:611–619. doi: 10.4040/jkan.2010.40.5.611.
5. Choe MA, An GJ, Lee YK, Im JH, Choi-Kwon S, Heitkemper M. Effect of inactivity and undernutrition after acute ischemic stroke in a rat hindlimb muscle model. Nursing Research. 2004. 53:283–292.
6. Choe MA, Kim KH, An GJ, Lee KS, Choi JA. Hindlimb muscle atrophy of rat induced by neuropathic pain. Journal of Korean Biological Nursing Science. 2008. 10:88–95.
7. Choe MA, Kim KH, An GJ, Lee KS, Heitkemper M. Hindlimb muscle atrophy occurs from peripheral nerve damage in a rat neuropathic pain model. Biological Research for Nursing. 2011. 13:44–54. doi: 10.1177/1099800410382291.
8. Choi JW, In JH, Kim YS, Kang YJ, Im YG, Cho SM, et al. Low dose ketamine reduces the induction of ERK1/2 and CREB signaling protein in a neuropathic pain model of rats. Korean Journal of Anesthesiology. 2009. 57:210–216.
9. Dixon WJ. Efficient analysis of experimental observations. Annual Review of Pharmacology and Toxicology. 1980. 22:441–462.
10. Han SH, Lee SC, Kim YC, Lim YJ, Sung JS. Effect of L-NAME on neuropathic pain developed after peripheral nerve injury. Korean Journal of Anesthesiology. 2002. 43:494–506.
11. Joo MJ, Lee KJ, Shin KH, Kim JC. Nitric oxide-mediated neurotoxicity after excimer laser photorefractive keratectomy. Journal of the Korean Ophthalmological Society. 1999. 40:688–698.
12. Khanna A, Cowled PA, Fitridge RA. Nitric oxide and skeletal muscle reperfusion injury: Current controversies. Journal of Surgical Research. 2005. 128:98–107. doi: 10.1016/j.jss.2005.04.020.
13. Kibaly C, Meyer L, Patte-Mensah C, Mensah-Nyagan AG. Biochemical and functional evidence for the control of pain mechanism by dehydroepiandrosterone endogenously synthesized in the spinal cord. The FASEB Journal. 2008. 22:93–104. doi: 10.1096/fj.07-8930com.
14. Kim JY. Effects of short-term undernutrition on type I and II muscles in rat. 2005. Seoul: Seoul National University;Unpublished master's thesis.
15. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992. 50:355–363.
16. Lee KC, Choi YS, Lee HB, Park ST. Effect of NMDA receptor antagonist and NOS inhibitor on spinal sensory neurons of neuropathic pain animal model. The Korean Journal of Pain. 2002. 15:13–18.
17. Leem JW, Gwak YS, Chung SS, Lee KR, Yoon DM, Nam DS. Effects of NO Synthase inhibitor on responsiveness of dorsal horn neurons in neuropathic pain animal model. Journal of the Korean Pain Society. 2000. 13:19–30.
18. Long JP, Greco SC. The effect of propofol administered intravenously on appetite stimulation in dogs. Contemporary Topics in Laboratory Animal Science. 2000. 39(6):43–46.
19. Martinez JA, Francis GJ, Liu WQ, Pradzinsky N, Fine J, Wilson M, et al. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience. 2008. 157:908–925. doi: 10.1016/j.neuroscience.2008.08.073.
20. Morley JE, Kraenzle D. Causes of weight loss in a community nursing home. Journal of the American Geriatrics Society. 1994. 42:583–585.
21. Pizza FX, Hernandez IJ, Tidball JG. Nitric oxide synthase inhibition reduces muscle inflammation and necrosis in modified muscle use. Journal of Leukocyte Biology. 1998. 64:427–433.
22. Qi WN, Zhang L, Chen LE, Seaber AV, Urbaniak JR. Nitric oxide involvement in reperfusion injury of denervated muscle. The Journal of Hand Surgery. 2004. 29:638–645. doi: 10.1016/j.jhsa.2004.01.003.
23. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y, et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. The Journal of Clinical Investigation. 2007. 117:2468–2476. doi: 10.1172/JCI30654.
24. Thomas DA, Ren K, Besse D, Ruda MA, Dubner R. Application of nitric oxide synthase inhibitor L-NAME, on injured nerve attenuates neuropathy induced thermal hyperalgesia in rats. Neuroscience Letters. 1996. 210:124–126. doi: 10.1016/0304-3940(96)12670-7.
25. Trifiletti RR. Neuroprotective effects of NG-nitro-L-arginine in focal stroke in the 7-day old rat. European Journal of Pharmacology. 1992. 218:197–198. doi: 10.1016/0014-2999(92)90168-4.
26. Wadley GD, McConell GK. Effect of nitric oxide synthase inhibition on mitochondrial biogenesis in rat skeletal muscle. Journal of Applied Physiology. 2007. 102:314–320. doi: 10.1152/japplphysiol.00549.2006.
27. Wang SM, Tsai HP, Huang HC, Lin JL, Liu PH. Inhibition of nitric oxide synthase promotes facial axonal regeneration following neurorrhaphy. Experimental Neurology. 2009. 216:499–510.
28. Wang Q, Wang F, Hong G. Inhibitor of nitric oxide synthase on the denervated muscle atrophy. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006. 20:805–808.
29. Yoon YW, Sung B, Chung JM. Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model. NeuroReport. 1998. 9:367–372.
TOOLS
Similar articles